MACROH2A1 and hepatocellular carcinoma: In response to the chemotherapeutic and DNA-demethylating agent 5-aza-deoxycytidine, transgenic expression of macroH2A1 isoforms in HCC cell lines prevented the emergence of a senescent-like phenotype and induced synergistic global DNA hypomethylation [78].